Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting VEGF in cancer therapy.

× No keyword cloud information.

8 in total

Review 1. The von Hippel-Lindau gene: turning discovery into therapy.

Authors: Peter E Clark; Michael S Cookson
Journal: Cancer Date: 2008-10-01 Impact factor: 6.860

2. Cabozantinib Loaded DSPE-PEG₂₀₀₀ Micelles as Delivery System: Formulation, Characterization and Cytotoxicity Evaluation.

Authors: Qiuhong Yang; Ryan Moulder K; Mark S Cohen; Shuang Cai; Laird M Forrest
Journal: BAOJ Pharm Sci Date: 2015-01-05

Review 3. XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC.

Authors: Ying Zhang; Fadila Guessous; Alex Kofman; David Schiff; Roger Abounader
Journal: IDrugs Date: 2010-02

4. Rationale for targeted therapies and potential role of pazopanib in advanced renal cell carcinoma.

Authors: Peter E Clark
Journal: Biologics Date: 2010-08-09

Review 5. The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.

Authors: Peter E Clark
Journal: Kidney Int Date: 2009-08-05 Impact factor: 10.612

6. Serum vascular endothelial growth factor and angiopoietin-2 are associated with the severity of systemic inflammation rather than the presence of hemoptysis in patients with inflammatory lung disease.

Authors: Hye Yun Park; Cho Rom Hahm; Kyeongman Jeon; Won-Jung Koh; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Sang-Won Um
Journal: Yonsei Med J Date: 2012-03 Impact factor: 2.759

7. Efficacy and Toxicity Assessment of Different Antibody Based Antiangiogenic Drugs by Computational Docking Method.

Authors: Sayan Mukherjee; Gopa Chatterjee; Moumita Ghosh; Bishwajit Das; Durjoy Majumder
Journal: Adv Bioinformatics Date: 2016-03-07

8. Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells.

Authors: David Muench; Francine Rezzoug; Shelia D Thomas; Jingjing Xiao; Ashraful Islam; Donald M Miller; Kara C Sedoris
Journal: PLoS One Date: 2019-01-25 Impact factor: 3.240